BiomX Inc.
PHGE
$0.601
-$0.01-1.64%
AMEX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -14.51M | 9.64M | 4.47M | -17.33M | -5.49M |
Total Depreciation and Amortization | 921.00K | 322.00K | 331.00K | 229.00K | 212.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | 114.00K |
Total Other Non-Cash Items | 6.04M | -18.85M | -13.72M | 8.46M | 661.00K |
Change in Net Operating Assets | 1.26M | 784.00K | -2.32M | -2.72M | -1.74M |
Cash from Operations | -6.29M | -8.10M | -11.24M | -11.36M | -6.24M |
Capital Expenditure | -11.00K | -10.00K | -9.00K | -- | -7.00K |
Sale of Property, Plant, and Equipment | 10.00K | 9.00K | 63.00K | -- | 1.00K |
Cash Acquisitions | 0.00 | 0.00 | 0.00 | 663.00K | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | 0.00 |
Cash from Investing | -1.00K | -1.00K | 54.00K | 663.00K | -6.00K |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 0.00 | 0.00 | 0.00 | -10.75M | -1.32M |
Issuance of Common Stock | 0.00 | 0.00 | 1.00K | 24.00K | 0.00 |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | 0.00 | 0.00 | 0.00 | 21.27M | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -398.00K | 0.00 | -204.00K | 28.43M | 0.00 |
Cash from Financing | -398.00K | 0.00 | -203.00K | 38.98M | -1.32M |
Foreign Exchange rate Adjustments | 12.00K | 35.00K | -15.00K | -31.00K | 43.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -6.68M | -8.06M | -11.40M | 28.25M | -7.53M |